#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer recurrent Cerebral amyloid angiopathy Malignant melanoma Brain injury Haemophilia A without inhibitors Complex regional pain syndrome IgA nephropathy Fibrosarcoma Round cell liposarcoma Cholestatic pruritus Rhabdomyosarcoma Adenoid cystic carcinoma Cystic fibrosis gastrointestinal disease Hereditary haemorrhagic telangiectasia Cystic fibrosis respiratory infection suppression More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Basic Information Factor VIII deficiency – Diagnostics Hepatic angiosarcoma – Trials in Disease Haemophagocytic lymphohistiocytosis – Life with Disease Haemophilia A without inhibitors – Trials in Disease Acute respiratory distress syndrome – Treatment Burkitt’s lymphoma – Life with Disease Andersen-Tawil syndrome – Diagnostics Factor IX deficiency Hyperoxaluria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mps-216 Pitolisant Metformin Embonate Ttf-Ngr Fluticasone Furoate Tioguanine Tiemonium Methylsulphate Anhydrous Cyclophosphamide Ifinatamab Deruxtecan Ziprasidone Human Von Willebrand Factor Clebopride Hydrogen Maleate Artemisia Vulgaris (312) Noradrenaline Tartrate Opium, Standardized Powdered Arbaclofen L-Glutamic Acid 18F-Fludarabine Enasidenib Mesilate Imiquimod More therapies…

    Learn about Your Condition

    Biliary neoplasm Tympanic membrane hyperaemia Radius fracture Short-bowel syndrome Endometrial cancer stage III Friedreich's ataxia Synovial sarcoma metastatic Thymoma malignant Kaposi's sarcoma Mitral valve incompetence Cleft lip and palate Chronic hepatitis C Psychological trauma Conjunctivitis allergic Pancreatic neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Autoimmune haemolytic anaemia

  • A study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    • Immune thrombocytopenia
    Investigated Drugs:
    • Tafasitamab
    France Italy The Netherlands Spain

  • Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

    Recruiting

    3 1
    Investigated Drugs:
    • Rilzabrutinib
    Austria Czechia Denmark Germany Greece Hungary +5

  • Study on the Effectiveness of Apixaban and Enoxaparin Sodium in Preventing Blood Clots in Patients with Autoimmune Hemolytic Anemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    Investigated Drugs:
    • Apixaban
    • Enoxaparin Sodium
    France

  • Study of cc-97540 CD19‑Targeted NEX‑T CAR T in participants with chronic immune thrombocytopenia and autoimmune hemolytic anemia

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • CC-97540
    Denmark Germany

  • Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Long-Term Safety Study of Riliprubart in Patients with Cold Agglutinin Disease

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    Investigated Drugs:
    • Riliprubart
    Germany Italy The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!